RT Journal
A1 Kirkcaldy RD, Bolan GA, Wasserheit JN
T1 CEphalosporin-resistant gonorrhea in north america
JF JAMA
JO JAMA
YR 2013
FD January 9
VO 309
IS 2
SP 185
OP 187
DO 10.1001/jama.2012.205107
UL http://dx.doi.org/10.1001/jama.2012.205107
AB 
Gonorrhea has affected humans for centuries and remains common. Worldwide, an estimated 106.1 million cases occur annually.1 In 2011, gonorrhea again was the second most commonly reported notifiable infection in the United States with 321 849 cases reported.2 Because gonorrhea often can be asymptomatic, the true disease burden may be closer to 700 000.3 Gonorrhea disproportionately affects racial, ethnic, and sexual minorities. Untreated gonococcal infection can lead to pelvic inflammatory disease, ectopic pregnancy, and infertility in women and can facilitate transmission of human immunodeficiency virus.4 Childhood blindness still affects infants born to mothers infected with gonorrhea, particularly in resource-limited countries.